Method of controlling a polypeptide modification reaction
AssigneeNovo Nordisk Healthcare AG
InventorsLars Sejergaard, Janus Krarup
Life of this patent
Estimating the term…
Abstract
The invention relates to a method of controlling a polypeptide modification reaction, in particular but not exclusively, a method of controlling the activation of human factor VII (FVII) to produce human factor VII(a) (FVII(a)). The invention also relates to polypeptides obtainable by the polypeptide modification reaction and to pharmaceutical compositions comprising said polypeptides.
Claims13
A method of obtaining a required proportion of activated factor VII, or an analogue or derivative thereof in a purified batch of factor VII/VIIa or an analogue or derivative thereof, which comprises the steps of:
- (a) measuring the initial concentration of the factor VII/VIIa, or analogue or derivative thereof;
- (b) measuring the initial proportion of activated factor VII, or analogue or derivative thereof;
- (c) calculating the activation reaction time of the factor VII, or analogue or derivative thereof, by correlation of the values measured in each of steps (a) and (b) with a value of required proportion of activated factor VII, or analogue or derivative thereof, the reaction time, t, being calculated in accordance with formula (I):
- t
- =
- -
- ln
-
- (
- akt
-
-
- 0
- ·
- (
- akt
- -
- 1
- )
- akt
- ·
- (
- akt
-
-
- 0
- -
- 1
- )
- )
- k
-
- (
- T
- )
- ·
- xb
- ·
- F
-
-
- 0
- (
- I
- )
- wherein “akt” refers to the required proportion of activated factor VII, or analogue or derivative thereof, “akt0” refers to the initial proportion of activated factor VII, or analogue or derivative thereof, measured in step (b), “F0” refers to the initial concentration of the factor VII, or analogue or derivative thereof, (in g/l) measured in step (a), k(T) refers to the reaction constant for the given reaction (in L/g/min) as a function of temperature, T, and xb refers to the molar fraction, calculated according to the equation in formula (III),
- xb
- =
- 10
- p
-
-
- H
- -
- 7.61
- 1
- +
- 10
- p
-
-
- H
- -
- 7.61
- (
- III
- )
- wherein pH refers to the selected pH of the reaction;
- (d) performing, at a pH of 6.0 to 8.0, the factor VII activation reaction, for the time calculated in step (c);
- and
- (e) terminating the reaction after the reaction time calculated in step (c), thereby obtaining the required proportion of the activated factor VII, or analogue or derivative thereof, wherein the terminating comprises lowering the pH to a value below about 6.0,
- wherein the activated factor VII, or analogue or derivative thereof, is wt-FVIIa, K157A-FVIIa, V158T/M298Q-FVIIa, V158D/M298Q-FVIIa, V158D/M298K-FVIIa, V158D/E296V/M298Q-FVIIa, M298Q-FVIIa, V158D/E296V/M298Q/K337A-FVIIa, S336G-FVIIa, or K337A-FVIIa.
A method of preventing degradation of an activated factor VII, or an activated factor VII analogue or derivative, in a purified batch of factor VII/VIIa or analogue or derivative thereof, to obtain a required proportion of activated factor VII, or an analogue or derivative thereof, said method comprising the steps of:
- (a) measuring the initial concentration of the factor VII/VIIa, or analogue or derivative thereof;
- (b) measuring the initial proportion of activated factor VII, or analogue or derivative thereof;
- (c) calculating the activation reaction time of the factor VII, or analogue or derivative thereof, by correlation of the values measured in each of steps (a) and (b) with a value of required proportion of activated factor VII, or analogue or derivative thereof, the reaction time, t, being calculated in accordance with formula (I):
- t
- =
- -
- ln
-
- (
- akt
-
-
- 0
- ·
- (
- akt
- -
- 1
- )
- akt
- ·
- (
- akt
-
-
- 0
- -
- 1
- )
- )
- k
-
- (
- T
- )
- ·
- xb
- ·
- F
-
-
- 0
- (
- I
- )
- wherein “akt” refers to the required proportion of activated factor VII, or analogue or derivative thereof, “akt0” refers to the initial proportion of activated factor VII, or analogue or derivative thereof, measured in step (b), “F0” refers to the initial concentration of the factor VII, or analogue or derivative thereof, (in g/l) measured in step (a), k(T) refers to the reaction constant for the given reaction (in L/g/min) as a function of temperature, T, and xb refers to the molar fraction, calculated according to the equation in formula (III),
- xb
- =
- 10
- p
-
-
- H
- -
- 7.61
- 1
- +
- 10
- p
-
-
- H
- -
- 7.61
- (
- III
- )
- wherein pH refers to the selected pH of the reaction;
- (d) performing, at a pH of 6.0 to 8.0, the factor VII activation reaction, for the time calculated in step (c);
- and
- (e) terminating the reaction after the reaction time calculated in step (c), thereby obtaining the required proportion of the activated factor VII, or analogue or derivative thereof, wherein the terminating comprises lowering the pH to a value below about 6.0,
- wherein the activated factor VII, or analogue or derivative thereof, is wt-FVIIa, K157A-FVIIa, V158T/M298Q-FVIIa, V158D/M298Q-FVIIa, V158D/M298K-FVIIa, V158D/E296V/M298Q-FVIIa, M298Q-FVIIa, V158D/E296V/M298Q/K337A-FVIIa, S336G-FVIIa, or K337A-FVIIa.
Dependencies are inferred from the claim text.